| Literature DB >> 28198206 |
Mariem Chaâbane1,2, Mohamed Koubaa3, Nejla Soudani1, Awatef Elwej1, Malek Grati4, Kamel Jamoussi4, Tahia Boudawara5, Semia Ellouze Chaabouni2, Najiba Zeghal1.
Abstract
CONTEXT: Nitraria retusa (Forssk.) Asch. (Nitrariaceae) is a medicinal plant which produces edible fruits whose antioxidant activity has been demonstrated.Entities:
Keywords: Triazole fungicides; nephrotoxicity; nitrariaceae; polyphenols
Mesh:
Substances:
Year: 2017 PMID: 28198206 PMCID: PMC6130529 DOI: 10.1080/13880209.2016.1278455
Source DB: PubMed Journal: Pharm Biol ISSN: 1388-0209 Impact factor: 3.503
Mineral content of N. retusa fruit.
| Minerals | Concentration (mg/100 g |
|---|---|
| Mg2+ | 54.69 |
| Na+ | 410.82 |
| Ca2+ | 101.82 |
| Zn2+ | 0.48 |
| Fe2+ | 6.78 |
| Cu2+ | 0.322 |
Mg2+: magnesium, Na+: sodium, Ca2+: calcium, Zn2+: zinc, Fe2+: iron, Cu2+: copper.
Figure 1.HPLC–HRMS chromatogram representing the polyphenols extracted from the aqueous extract of N. retusa fruit and chemical structure of the major components identified [hydroxycaffeic acid (1), 3-O-methylgallic acid (2), p-coumaric acid (3), 3′-O-methyl-(-)-epicatechin 7-O-glucuronide (4), 4′-O-methyl-(-)-epicatechin 3′-O-glucuronide (5), epicatechin 3′-O-glucuronide (6), taxifoline (7), kaempferol (8), cyanidin 3-O-rutinoside (9), chlorogenic acid (10) and kaempferol 3-glucoside (11)]. The identification was performed according to a home-generated database containing 500 compounds and a mixture of standards containing 30 phenolic compounds.
Body, absolute and relative kidney weights. Food and water intake of control and treated rats with penconazole (PEN), N. retusa aqueous extract (NRE), or their combination (NRE + PEN).
| Parameters and treatments | Controls | PEN | NRE + PEN | NRE |
|---|---|---|---|---|
| Initial body weight (g) | 248.67 ± 8.48 | 249.67 ± 5.61 | 251.67 ± 4.27 | 254.17 ± 6.43 |
| Final body weight (g) | 261.00 ± 6.81 | 264.33 ± 5.20 | 262.00 ± 4.86 | 267.67 ± 9.18 |
| Absolute kidney weight (g) | 1.61 ± 0.15 | 1.68 ± 0.10 | 1.61 ± 0.06 | 1.76 ± 0.17 |
| Relative kidney weight (g/100g bw) | 0.62 ± 0.05 | 0.63 ± 0.03 | 0.61 ± 0.02 | 0.66 ± 0.05 |
| Food intake (g/day/rat) | 16.68 ± 1.59 | 16.08 ± 1.77 | 15.89 ± 1.55 | 16.39 ± 1.42 |
| Water intake (mL/day/rat) | 25.47 ± 2.45 | 33.16 ± 2.64 | 26.07 ± 2.22 | 26.03 ± 1.64 |
Values are means ± SD for six rats in each group.
bw: body weight.
PEN group vs. control group:
p < 0.001.
NRE + PEN group vs PEN group:
p < 0.001.
Urinary volume, creatinine clearance, plasma and urinary levels of creatinine, urea and uric acid, and BUN of control and treated rats with penconazole (PEN), N. retusa aqueous extract (NRE) or their combination (NRE + PEN).
| Parameters and treatments | Controls | PEN | NRE + PEN | NRE |
|---|---|---|---|---|
| Urinary volume (mL/24 h) | 5.33 ± 0.41 | 14.00 ± 1.87 | 11.67 ± 0.41 | 7.67 ± 1.08 |
| Creatinine clearance (μL/min) | 536.75 ± 81.31 | 339.58 ± 39.50 | 533.28 ± 88.10 | 640.26 ± 83.20 |
| Creatinine (μmol/L) | ||||
| Plasma | 52.40 ± 3.12 | 62.62 ± 6.12 | 54.67 ± 4.86 | 54.34 ± 0.96 |
| Urine | 7551.25 ± 573.05 | 2216.67 ± 440.08 | 3580.63 ± 526.25 | 6550.00 ± 39.53 |
| Urea (mmol/L) | ||||
| Plasma | 5.82 ± 0.39 | 9.35 ± 0.48 | 7.38 ± 0.25 | 6.49 ± 0.23 |
| Urine | 472.61 ± 66.84 | 161.22 ± 9.60 | 234.16 ± 31.28 | 359.57 ± 19.09 |
| Uric acid (μmol/L) | ||||
| Plasma | 73.13 ± 6.04 | 120.71 ± 9.60 | 64.53 ± 5.30 | 76.93 ± 3.70 |
| Urine | 247.50 ± 39.47 | 131.67 ± 14.72 | 147.5 ± 7.58 | 215.00 ± 30.17 |
| BUN | 2.72 ± 0.18 | 4.37 ± 0.22 | 3.45 ± 0.12 | 3.06 ± 0.11 |
Values are means ± SD for six rats in each group.
BUN: blood urea nitrogen.
BUN was calculated using the formula conversion:
BUN (mmol/L) = [urea(mmol/L)]/2.14.
PEN, NRE + PEN and NRE groups vs. control group:
p < 0.05.
p < 0.01.
p < 0.001.
NRE + PEN group vs PEN group:
p < 0.05.
p < 0.01.
p < 0.001.
Plasma ALP, GGT and LDH activities and kidney LDH activity in control and treated rats with penconazole (PEN), N. retusa aqueous extract (NRE) or their combination (NRE + PEN).
| Parameters and treatments | Controls | PEN | NRE + PEN | NRE |
|---|---|---|---|---|
| Plasma | ||||
| ALP (IU/L) | 122.5 ± 13.65 | 95.42 ± 5.94 | 103.08 ± 5.60 | 112.67 ± 5.49 |
| GGT (IU/L) | 11.50 ± 1.75 | 7.44 ± 0.50 | 9.52 ± 0.84 | 12.30 ± 2.43 |
| LDH (IU/L) | 1162.33 ± 97.84 | 1824.17 ± 94.96 | 1274.67 ± 89.08 | 1312.00 ± 21.43 |
| Kidney | ||||
| LDH (IU/L) | 3.37 ± 0.29 | 2.63 ± 0.23 | 2.97 ± 0.29 | 3.27 ± 0.22 |
Values are means ± SD for six rats in each group.
ALP: alkaline phosphatase, GGT: gamma glutamyltranspeptidase, LDH: Lactate dehydrogenase.
PEN, NRE + PEN and NRE groups vs. control group:
p < 0.05.
p < 0.01.
p < 0.001.
NRE + PEN group vs PEN group:
p < 0.05.
p < 0.001.
Kidney MDA, H2O2, PCO, AOPP, NPSH, GSH and MT levels in control and treated rats with penconazole (PEN), N. retusa aqueous extract (NRE) or their combination (NRE + PEN).
| Parameters and treatments | Controls | PEN | NRE + PEN | NRE |
|---|---|---|---|---|
| MDA (nmol/g tissue) | 142.75 ± 9.63 | 238.01 ± 18.62 | 213.81 ± 15.14 | 147.22 ± 16.49 |
| H2O2 (nmol/mg protein) | 0.042 ± 0.004 | 0.064 ± 0.005 | 0.056 ± 0.005 | 0.045 ± 0.004 |
| PCO (nmol/mg protein) | 0.59 ± 0.05 | 0.84 ± 0.05 | 0.75 ± 0.06 | 0.56 ± 0.05 |
| AOPP (nmol/mg protein) | 0.20 ± 0.02 | 0.37 ± 0.02 | 0.31 ± 0.01 | 0.21 ± 0.02 |
| NPSH (μmol/g tissue) | 2.40 ± 0.12 | 2.76 ± 0.05 | 2.50 ± 0.04 | 2.47 ± 0.07 |
| GSH (μg/g tissue) | 29.74 ± 1.45 | 34.05 ± 2.30 | 31.55 ± 1.08 | 30.86 ± 0.71 |
| MT (μmol GSH/g tissue) | 0.49 ± 0.01 | 0.57 ± 0.06 | 0.50 ± 0.03 | 0.47 ± 0.04 |
Values are means ± SD for six rats in each group.
MDA: malondialdehyde, H2O2: hydrogen peroxide, PCO: protein carbonyls, AOPP: advanced oxidation protein products, NPSH: non-protein thiols, GSH: reduced glutathione MT: metallothionein.
PEN and NRE + PEN groups vs. control group:
p < 0.05.
p < 0.01.
p < 0.001.
NRE + PEN group vs PEN group:
p < 0.05.
p < 0.001.
Figure 2.Antioxidant enzyme activities (A) CAT, (B) SOD and (C) GPx in kidney of control and treated rats with penconazole (PEN), N. retusa aqueous extract along with penconazole (NRE + PEN) and N. retusa aqueous extract (NRE). Values are means ± SD for six rats in each group. PEN and NRE + PEN groups vs control group: *p < 0.05; **p < 0.01; ***p < 0.001. NRE + PEN group vs PEN group: #p < 0.05; ##p < 0.01; ###p < 0.001
Figure 3.Histological kidney sections of (A) control and (B1, B2 and B3) treated rats with penconazole, (C) N. retusa aqueous extract along with penconazole and (D) N. retusa aqueous extract. Optic microscopy: H&E (400×). Arrows indicate: Glomeruli fragmentation, necrosis of the epithelial cells lining the tubules, Bowman’s space enlargement, inflammatory leucocytes infiltration
Grading of the histopathological changes in the kidney sections.
| Groups | Enlarged Bowman’sspace | Glomerulifragmentation | Necrosis of the epithelial cellslining the tubules | Infiltration ofleucocytes |
|---|---|---|---|---|
| Controls | − | − | − | − |
| PEN | ++ | +++ | +++ | +++ |
| NRE + PEN | − | − | + | − |
| NRE | − | − | − | − |
Scoring was done as follows: none (−), mild (+), moderate (++) and severe (+++).